Completed PHASE3 INTERVENTIONAL NCT00050479

Laser and Medical Treatment of Diabetic Macular Edema

Preliminary Multi-Center Assessment of Laser and Medical Treatment of Diabetic Macular Edema

Sponsor: National Eye Institute (NEI)

Updated 5 times since 2017 Last updated: Jul 18, 2006 Started: Dec 31, 2002 Completion: Jul 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Macular Degeneration, this trial is completed. The trial is conducted by National Eye Institute (NEI) and has accumulated 5 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Eye Institute (NEI)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States